NCT03447080 is a NA clinical trial of Control in Diabetes Mellitus, Type 2, sponsored by Singapore Institute of Food and Biotechnology Innovation.

Who is sponsoring NCT03447080?

NCT03447080 is sponsored by Singapore Institute of Food and Biotechnology Innovation.

What drugs are being tested in NCT03447080?

Interventions in NCT03447080: Control, Control, Ricebran soybean milk, Soybean milk.

What condition does NCT03447080 study?

NCT03447080 studies Diabetes Mellitus, Type 2.

Is NCT03447080 still recruiting?

NCT03447080 is currently completed. Last updated 13 May 2019.

Last reviewed 2019-05-13 · How we verify

NCT03447080

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Co-ingestion of Rice Bran Soymilk or Plain Soymilk With White Bread: Effects on the Glycaemic and Insulinaemic Response

Completed NA Last updated 13 May 2019

What this trial tests

NA trial testing Control in Diabetes Mellitus, Type 2 in 17 participants. Completed in 18 January 2019.

Timeline

2 June 2017

Primary endpoint
18 January 2019

18 January 2019

Quick facts

Lead sponsor	Singapore Institute of Food and Biotechnology Innovation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	17
Start date	2 June 2017
Primary completion	18 January 2019
Estimated completion	18 January 2019
Sites	1 location across Singapore

Drugs / interventions tested

Control
Control
Ricebran soybean milk
Soybean milk

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

Singapore Institute of Food and Biotechnology Innovation

Who can join

Adults 21 to 60, male only, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

bread and that rice-bran soymilk will have an additional beneficial effect on the glucose and insulin The proposed research project is important because it will provide, for the first time, evidence on the benefits of the addition of rice-bran to soymilk by measuring the acute effect on the glycaemic and insulinaemic response in co-consumption with a high GI meal in Asians. Investigators hypothesize that soymilk will lower the glycaemic and insulinaemic response of white response. This will have an important implication for public health as investigators will understand better how additional dietary fibre can improve the local diet which is typically of high GI values. Ultimately, results from this project will enable the development of dietary recommendations for better glycaemic control in Asian people.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Control

Trials testing the same drug.

NCT06064604 — Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke · NA · not yet recruiting
NCT04039386 — Psychosocial Interventions for Young Adults With Hip Pain · NA · not yet recruiting
NCT07042373 — Effects of Tobacco Abuse Liability-dependent Taxes in the ETM · NA · not yet recruiting
NCT07512999 — The Effect of Using Nature Sounds and Virtual Reality During the Non-Stress Test · NA · not yet recruiting
NCT07531563 — Protein Supplementation for Radiation- Induced Oral Mucositis in Head and Neck Cancer Patients Receiving Radiotherapy · NA · not yet recruiting

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Singapore Institute of Food and Biotechnology Innovation trials

Trials by the same sponsor.

NCT07397754 — Sodium-rich COndiments Unifying Health and Taste · NA · recruiting
NCT06691126 — Pharmacokinetic Study of Terpinolene in Healthy Subjects (PKT Study) · NA · completed
NCT06421194 — Functional and Nutritional Plant-based Mixed Protein Study (FuN Protein Study) · NA · recruiting
NCT06119035 — Insulin Modelling Based on Plasma Glucose Measures Via a Minimally-Invasive Glucose Sensor · NA · completed
NCT06640335 — The Effects of Vegetable Preloading on Postprandial Glycemia, Insulinaemia and Gastric Emptying · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03447080 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Singapore Institute of Food and Biotechnology Innovation
Last refreshed: 13 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03447080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing